Mitochondrial Unfolded Protein Response (UPRmt): Proteostasis, Hormesis, And Chronic Stress

The Mitochondrial Unfolded Protein Response (UPRmt) is a stress signaling system that tries to restore protein quality when mitochondria can no longer fold, import, or clear proteins efficiently.

In this post, we will discuss mitochondrial proteostasis, the OMA1-DELE1-HRI pathway, Activating Transcription Factor 4 (ATF4), Activating Transcription Factor 5 (ATF5), C/EBP Homologous Protein (CHOP), Sirtuin 3 (SIRT3), mitochondrial chaperones and proteases, mitohormesis, genetics, and why chronic unresolved stress can become harmful.

---

What The UPRmt Is

The UPRmt is the mitochondria-to-nucleus response that changes gene expression when mitochondrial protein folding, import, translation, respiration, or degradation is disturbed.

The term does not describe one binary switch in mammals.

It describes overlapping stress programs that can include the UPRmt, the **Integrated Stress Response** (ISR), mitophagy, antioxidant signaling, and changes in mitochondrial translation.

The original mammalian UPRmt experiments used a misfolded mitochondrial protein and showed increased expression of nuclear genes encoding mitochondrial chaperones and the protease CLPP, without activating the canonical endoplasmic reticulum stress proteins in the same way. R

The modern interpretation is broader because many mitochondrial stressors activate retrograde signals even when the initiating problem is not a literal accumulation of unfolded protein.

Mitochondrial translation inhibition, impaired protein import, respiratory chain disruption, loss of membrane potential, and oxidative injury can all produce overlapping mitochondrial stress signatures. R R

The important distinction is that a stress signature tells you that the cell is responding, not that the response is succeeding.

Mitochondrial Proteostasis is the continuous process of importing, folding, assembling, repairing, and removing mitochondrial proteins.

Mitochondria must coordinate proteins encoded by nuclear DNA with proteins encoded by mitochondrial DNA, so mismatched production rates can create proteotoxic stress even when the individual proteins are not intrinsically defective. R

Common UPRmt inputs (not an exclusive list):

• Electron transport chain disruption can activate mitochondrial stress signaling without proving that unfolded proteins are the primary lesion. R
• Import stress can prevent nuclear-encoded proteins from reaching the mitochondrial compartment where they are needed. R
• Mitochondrial translation imbalance can create an uneven supply of mitochondrial and nuclear-encoded respiratory-chain subunits. R
• Protein misfolding can overwhelm chaperones and proteases inside the mitochondrial matrix. R
• Reactive oxygen species can chemically damage proteins and increase the burden placed on mitochondrial quality-control systems. R

The UPRmt is therefore best understood as a resource-allocation response.

The cell reduces some forms of protein production, increases selected stress transcripts, expands folding and degradation capacity, and decides whether the organelle can be repaired or should be removed.

Mitochondrial Proteostasis

Mitochondrial proteostasis is not just about making more chaperones.

It depends on several linked systems that must work at the same time.

Chaperones bind unstable proteins, prevent aggregation, and sometimes give proteins another chance to reach a functional conformation.

Mitochondrial Heat Shock Protein 70 (mtHSP70) helps drive protein import and folding, while Heat Shock Protein 60 (HSP60) and Heat Shock Protein 10 (HSP10) form a chaperonin system that folds selected proteins inside the matrix. R R

Proteases remove proteins that cannot be repaired.

The matrix proteases Lon Protease 1 (LONP1) and Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit (CLPP) participate in the degradation of damaged proteins, while inner-membrane proteases monitor other mitochondrial compartments. R R

Mitochondrial dynamics segregate damaged sections of the network and help determine whether a mitochondrion can be repaired locally or should be removed through mitophagy. R

Mitochondrial translation must be restrained when the organelle cannot safely assemble new respiratory-chain proteins.

Reducing mitochondrial translation can lower the incoming proteotoxic load, but it also reduces respiratory capacity if the stress persists. R

Mitophagy removes mitochondria that have crossed the line from stressed to irreversibly dysfunctional.

The HRI branch of the ISR can selectively trigger mitophagy, but mitophagy does not always require ATF4, which is another reason not to treat every UPRmt-related signal as one linear cascade. R

The response fails when the rate of damage exceeds the capacity of these systems.

In that state, producing more HSP60 or LONP1 may be a sign that the cell is trying harder, not evidence that mitochondrial function has normalized.

The OMA1-DELE1-HRI Stress Relay

The OMA1-DELE1-HRI pathway is one of the clearest examples of how mitochondrial stress is translated into a cytosolic and nuclear response.

The pathway was mapped primarily in mammalian cell models, so its existence is mechanistically strong while its use as a human clinical readout remains preliminary.

1. OMA1 Cleaves DELE1

OMA1 is a stress-activated protease in the mitochondrial inner membrane.

When mitochondria are perturbed, OMA1 cleaves DAP3 Binding Cell Death Enhancer 1 (DELE1), producing a fragment that can leave the mitochondrial compartment. R

The exact initiating signal can differ by cell type and stressor, and newer work suggests that OMA1 is essential in some models but dispensable for DELE1 cleavage in others. R

2. DELE1 Activates HRI

Cytosolic DELE1 binds Heme-Regulated Eukaryotic Initiation Factor 2 Alpha Kinase (HRI), which is encoded by EIF2AK1.

HRI then becomes the eIF2α kinase that relays mitochondrial dysfunction into the ISR. R

This is a useful correction to older diagrams that treated PERK as the default kinase for every stress response.

PERK is strongly associated with endoplasmic reticulum stress, while the OMA1-DELE1-HRI pathway provides a direct mitochondrial route to eIF2α phosphorylation. R

3. HRI Phosphorylates eIF2α

HRI phosphorylates the alpha subunit of Eukaryotic Initiation Factor 2 (eIF2α).

Phosphorylated eIF2α lowers general translation initiation, which reduces the number of new proteins entering an already stressed proteostasis system. R

This does not shut protein synthesis off completely.

It changes the translation priority of the cell.

4. ATF4 And ATF5 Gain A Translation Advantage

Some stress-responsive messenger RNAs contain upstream open reading frames that make their translation more favorable when eIF2α is phosphorylated.

This allows Activating Transcription Factor 4 (ATF4) and ATF5 to increase while broad protein synthesis is being restrained. R R

ATF4 then changes amino-acid handling, redox programs, autophagy, and cell-fate signaling through the broader ISR.

ATF4 is not specific to mitochondrial stress because nutrient deprivation, viral signaling, endoplasmic reticulum stress, and other insults can activate it through different eIF2α kinases. R

5. The Nucleus Expands Mitochondrial Quality Control

The resulting transcriptional program can increase mitochondrial chaperones, proteases, antioxidant defenses, metabolic adaptation, and mitophagy.

The goal is to restore function with fewer incoming proteins and more capacity to fold or remove the proteins already present.

The relay is therefore a communication system, not a guarantee of repair.

ATF4, ATF5, And CHOP

The relationship between ATF4, ATF5, and CHOP is where simplified UPRmt diagrams become misleading.

ATF4 Is The Broad Stress Coordinator

ATF4 is a central transcriptional regulator of the mammalian mitochondrial stress response in several experimental systems.

A multi-omics study found that ATF4 was the main regulator induced by several mitochondrial stressors, while canonical ATF5-dependent UPRmt genes were surprisingly not activated in those conditions. R

ATF4 also reduces mitochondrial protein production and reprograms metabolism, which can protect the cell from additional stress but can lower oxidative phosphorylation if maintained. R

This is the first major evidence limit.

An increase in ATF4 is not equivalent to a clean, mitochondria-specific UPRmt response.

ATF5 Is A Proposed Mammalian UPRmt Regulator

ATF5 contains mitochondrial and nuclear targeting information that allows its location and function to change when mitochondrial import or function is disturbed.

The original mammalian ATF5 study found that ATF5 could reproduce a UPRmt-like transcriptional response in worms lacking ATFS-1 and that mammalian cells required ATF5 to maintain mitochondrial activity during stress. R

An in vivo mouse study later found that UPRmt induction before cardiac ischemia and reperfusion injury was protective in wild-type mice but not in mice lacking ATF5. R

That result is important, but it is not a human treatment result.

The study used pharmacological stressors in mice and tested the heart in an ex vivo perfusion model, so the finding should be labeled animal and preclinical evidence.

CHOP Can Support Repair Or Promote Cell Death

C/EBP Homologous Protein (CHOP), also called DDIT3, is a stress-responsive transcription factor that can participate in the induction of mitochondrial chaperones and proteases.

In the original mammalian UPRmt model, CHOP worked with CCAAT/Enhancer-Binding Protein Beta (C/EBPβ) to regulate mitochondrial stress genes such as HSP60, HSP10, and CLPP. R

CHOP is not inherently pro-survival or pro-death.

During a tolerable mitochondrial stress response, CHOP can contribute to a protective proteostasis program, while sustained proteotoxic stress can use the ATF4-CHOP axis to induce pro-apoptotic genes. R R

The practical distinction is duration, damage burden, and whether the cell can resolve the initiating problem.

The Mammalian UPRmt Is An Overlapping Network

Some mammalian mitochondrial stressors activate ATF4 and CHOP without increasing the canonical chaperone program.

Mitochondrial translation inhibition has been shown to activate the ISR through ATF4 without inducing the tested mtUPR genes in mouse and cell models. R

The cleanest interpretation is that UPRmt and ISR share components but are not interchangeable labels.

There is a big MAYBE around how much of the worm ATFS-1 model maps directly onto human physiology.

SIRT3 And Mitochondrial Recovery

Sirtuin 3 (SIRT3) is the main nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase inside mitochondria.

SIRT3 regulates proteins involved in electron transport, fatty-acid oxidation, antioxidant defense, mitochondrial protein synthesis, membrane integrity, and mitophagy. R R

SIRT3 is relevant to the UPRmt because mitochondrial protein stress is not solved by transcription alone.

The enzymes and chaperones already inside the organelle must remain functional while the cell is trying to repair the damage.

An experimental study found that SIRT3 coordinated antioxidant machinery and mitophagy during mitochondrial proteotoxic stress, and that SIRT3 inhibition worsened mitochondrial network damage and cell death. R

SIRT3 can also reduce oxidative pressure by deacetylating Superoxide Dismutase 2 (SOD2) and can influence the mitochondrial permeability transition pore through cyclophilin D. R

The SIRT3 response is context-dependent rather than automatically beneficial.

In a study involving human tissue, mice, and cultured liver cells, reduced HSP60 correlated with more severe fatty liver disease, while HSP60 overexpression preserved SIRT3 signaling and reduced mitochondrial stress in the experimental models. R

That finding is mechanistically interesting but does not establish that increasing HSP60 or SIRT3 is a treatment for fatty liver disease.

Cancer cells can also use mitochondrial stress responses to survive chemotherapy and maintain growth.

SIRT3 increased UPRmt markers and weakened cisplatin sensitivity in cultured breast cancer cells, which is in vitro evidence that indiscriminate UPRmt activation could be harmful in some cancer contexts. R

Hormesis Versus Chronic Unresolved Stress

Mitohormesis is the idea that a tolerable mitochondrial stressor can trigger a later state of increased resilience.

The stressor is not beneficial because damage is good.

The potential benefit comes from the adaptive response that follows a small, recoverable perturbation.

Mitochondrial stress can activate the UPRmt, ISR, antioxidant signaling, mitophagy, and systemic signals that change metabolism beyond the originally stressed cell. R R

When The Response Is Useful

The response is more likely to be adaptive when the stress is limited, the damage can be repaired, and the signal resolves after the challenge ends.

Temporary reduction in translation can protect mitochondrial proteostasis by reducing the number of new proteins entering the organelle during a folding crisis. R

Temporary increases in chaperones, proteases, antioxidant systems, and mitophagy can improve the quality of the remaining mitochondrial network. R R

This is the logic behind exercise, fasting, temperature transitions, and other physiological stressors being studied as mitohormetic signals, although direct human evidence for deliberate UPRmt manipulation remains limited. R

When The Response Becomes Chronic

The response becomes less protective when the initiating insult remains active or the cell cannot restore protein folding and respiratory function.

Persistently elevated ATF4 and CHOP can shift the cell toward metabolic restriction, inflammatory signaling, senescence, or apoptosis depending on the tissue and stressor. R R

The practical inference is that a strong UPRmt signal is not automatically a good signal.

The desirable state is a stress response that is activated enough to improve quality control and then quiet enough to permit normal mitochondrial function.

The Difference Between Adaptation And Exhaustion

An adaptive response increases repair capacity relative to the problem.

An unresolved response keeps spending energy on damage control while the organelle continues losing function.

That distinction matters in chronic disease because a cell can look transcriptionally active while remaining bioenergetically compromised.

The literature supports this concept mechanistically, but it does not provide a simple clinical threshold that separates adaptive UPRmt activity from chronic mitochondrial stress in an individual person. R R

Evidence Limits And Safety

UPRmt is a research framework, not a diagnosis that can be inferred from fatigue, exercise intolerance, or one isolated stress-related gene result.

Those symptoms and molecular signals are nonspecific, and the same ATF4 or CHOP response can arise from mitochondrial, endoplasmic reticulum, nutrient, oxidative, or inflammatory stress. R R

Do not use oligomycin, mitochondrial translation inhibitors, or other experimental UPRmt inducers as self-directed mitochondrial therapies.

The cardioprotection study that used UPRmt inducers was performed in mice and ex vivo perfused hearts, not in people. R

Do not assume that forcing a stress response will repair the mitochondria that created the signal.

If protein import, respiratory-chain assembly, nutrient supply, or mitochondrial membrane integrity remains impaired, increasing a downstream transcription factor may increase stress signaling without restoring function. R R

The UPRmt also overlaps with endoplasmic reticulum stress, so treating the mitochondrial side while ignoring a major ER stressor may leave the broader proteostasis problem intact.

Cancer is another reason to avoid simplistic UPRmt activation strategies.

UPRmt components can protect healthy cells, but tumors may use the same chaperones, proteases, and stress pathways to survive hostile conditions and chemotherapy.

An animal-only prostate cancer study found that HSP60 and CLPP supported advanced tumor growth, while a cultured breast cancer study found that SIRT3-mediated UPRmt reduced cisplatin sensitivity. R R

These findings do not mean that normal mitochondrial stress responses cause cancer.

They mean that the same pathway can be protective in one tissue and therapeutically undesirable in another.

For practical purposes, the safest interpretation is to support the conditions that allow mitochondrial quality control to resolve stress rather than chasing a higher UPRmt signal as an endpoint.

Mechanisms Of Action

Simple:

• Damage triage separates proteins that can be refolded from proteins that should be degraded.
• Load reduction slows selected protein production so the mitochondria do not receive more material than they can process.
• Mitochondrial communication sends a stress signal to the nucleus so the cell can change gene expression.
• Stress resolution depends on repairing the initiating problem, not just increasing the volume of the alarm.

Advanced:

• ATF4 translation increases when eIF2α phosphorylation changes translation initiation and favors stress-responsive messenger RNAs with upstream open reading frames, allowing metabolic, amino-acid, antioxidant, and cell-fate programs to change during mitochondrial dysfunction. R R
• Chaperone and protease induction increases HSP60, mtHSP70, CLPP, LONP1, and related quality-control capacity so unstable proteins can be refolded or removed from the mitochondrial network. R R
• OMA1-DELE1-HRI signaling converts mitochondrial stress into cytosolic HRI activation, eIF2α phosphorylation, and ATF4 translation through stress-dependent cleavage and relocalization of DELE1. R
• SIRT3 quality control links NAD+-dependent deacetylation to antioxidant defense, respiratory-chain function, membrane stability, mitochondrial protein synthesis, and mitophagy during proteotoxic stress. R R
• Translation attenuation reduces mitochondrial protein production during stress, which can protect against further proteotoxic loading but can also reduce oxidative phosphorylation when maintained too long. R R

Genetics

The genes below are mechanistically relevant to mitochondrial stress signaling, but this is a pathway map rather than a validated consumer-genetic scoring system.

ATF4

ATF4 encodes a stress-responsive transcription factor that coordinates amino-acid metabolism, redox control, autophagy, and cell-fate signals downstream of eIF2α phosphorylation.

Mitochondrial stress can activate ATF4 through the OMA1-DELE1-HRI relay, but ATF4 is not specific to mitochondrial stress. R R

ATF5

ATF5 encodes a bZIP transcription factor that can move between mitochondrial and nuclear compartments and promote mitochondrial recovery during stress.

ATF5 is a proposed mammalian counterpart to the worm UPRmt regulator ATFS-1, although mammalian studies do not always reproduce an ATF5-dominant response. R R

CLPP

CLPP encodes a mitochondrial matrix protease that removes selected damaged or misfolded proteins.

CLPP is induced in classic mammalian UPRmt models and participates in a broader mitochondrial protease network that can influence metabolism, respiratory function, and cell survival. R R

DELE1

DELE1 encodes a mitochondrial stress relay protein that can be cleaved and released into the cytosol after mitochondrial dysfunction.

The released DELE1 fragment activates HRI and is required for ATF4 translation in the OMA1-DELE1-HRI pathway. R

DDIT3 (CHOP)

DDIT3 encodes CHOP, a stress-responsive transcription factor that can regulate mitochondrial chaperone and protease genes.

CHOP can support mitochondrial stress adaptation in one context and contribute to apoptosis when proteostasis cannot be restored. R R

EIF2AK1 (HRI)

EIF2AK1 encodes HRI, an eIF2α kinase that responds to heme-related signals and mitochondrial stress.

HRI is the key kinase connecting cytosolic DELE1 to eIF2α phosphorylation in several mammalian mitochondrial stress models. R

HSPD1 (HSP60)

HSPD1 encodes HSP60, a mitochondrial chaperonin that assists the folding of proteins in the matrix.

HSP60 is a classic UPRmt target, but its increase can represent an attempted repair response and does not prove that mitochondrial function has recovered. R R

LONP1

LONP1 encodes a mitochondrial matrix protease that degrades damaged proteins and regulates additional aspects of mitochondrial protein quality control.

LONP1 dysfunction can impair protein clearance and respiratory-chain maintenance, while LONP1 induction can occur as part of the mitochondrial stress response. R R

OMA1

OMA1 encodes a stress-activated inner-membrane protease that can cleave DELE1 during mitochondrial dysfunction.

OMA1 is central to the canonical DELE1 relay in several cell models, although the exact protease requirements can vary with the cell type and import stressor. R R

SIRT3

SIRT3 encodes the main mitochondrial NAD+-dependent deacetylase and regulates proteins involved in redox defense, metabolism, membrane integrity, and mitochondrial quality control.

SIRT3 can improve stress tolerance in nonmalignant models while also supporting survival in some tumor models, so a higher SIRT3 signal is not automatically beneficial. R R

More Research

• Biomarker translation remains unresolved because research measurements of ATF4, ATF5, CHOP, HSP60, CLPP, or LONP1 do not yet provide a validated, tissue-independent measure of whether UPRmt signaling is adaptive or harmful in a person. R R
• Cancer biology needs careful separation from general mitochondrial health because tumor cells can use HSP60, CLPP, SIRT3, ATF4, and related stress programs to maintain growth or resist treatment (preliminary and model-dependent evidence). R R
• Human intervention studies are needed to determine whether exercise, fasting, temperature exposure, or other physiological stressors produce a durable and beneficial UPRmt response in specific patient groups rather than simply increasing stress signaling (preliminary translational evidence). R R
• Mitokine signaling may allow stressed mitochondria in one tissue to alter metabolism and stress responses in distant tissues, but much of the mechanistic evidence remains from worms and animal models. R The related role of neuropeptides is an important direction for future research.
• NRF2 crosstalk may help determine whether ATF4 signaling remains protective by increasing antioxidant and anti-apoptotic programs while restraining CHOP-driven cell death, but the balance is tissue-specific. R The broader NRF2 pathway is relevant here because redox control changes the amount of mitochondrial damage that the UPRmt must process.
• Pathway boundaries remain unsettled because mitochondrial translation inhibition can activate ATF4 and the ISR without inducing the canonical mtUPR genes measured in some models. R R
• Therapeutic timing may be decisive because preconditioning before cardiac ischemia was protective in mice, while persistent or tumor-associated UPRmt activity can support pathology or treatment resistance (animal-only and in vitro evidence). R R R